Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Microbiologyopen. 2021 Nov;10(6):e1249. doi: 10.1002/mbo3.1249.
In fungal pathogens, the transcription factor SrbA (a sterol regulatory element-binding protein, SREBP) and CBC (CCAAT binding complex) have been reported to regulate azole resistance by competitively binding the TR34 region (34 mer) in the promoter of the drug target gene, erg11A. However, current knowledge about how the SrbA and CBC coordinately mediate erg11A expression remains limited. In this study, we uncovered a novel relationship between HapB (a subunit of CBC) and SrbA in which deletion of hapB significantly prolongs the nuclear retention of SrbA by increasing its expression and cleavage under azole treatment conditions, thereby enhancing Erg11A expression for drug resistance. Furthermore, we verified that loss of HapB significantly induces the expression of the rhomboid protease RbdB, Dsc ubiquitin E3 ligase complex, and signal peptide peptidase SppA, which are required for the cleavage of SrbA, suggesting that HapB acts as a repressor for these genes which contribute to the activation of SrbA by proteolytic cleavage. Together, our study reveals that CBC functions not only to compete with SrbA for binding to erg11A promoter region but also to affect SrbA expression, cleavage, and translocation to nuclei for the function, which ultimately regulate Erg11A expression and azole resistance.
在真菌病原体中,转录因子 SrbA(固醇调节元件结合蛋白,SREBP)和 CBC(CCAAT 结合复合物)已被报道通过竞争性结合药物靶基因 erg11A 启动子中的 TR34 区域(34 个碱基对)来调节唑类药物耐药性。然而,目前关于 SrbA 和 CBC 如何协调调节 erg11A 表达的知识仍然有限。在这项研究中,我们揭示了 HapB(CBC 的一个亚基)与 SrbA 之间的一种新关系,其中 hapB 的缺失通过增加其在唑类处理条件下的表达和切割,显著延长了 SrbA 的核保留时间,从而增强了 Erg11A 的表达以产生耐药性。此外,我们验证了缺失 HapB 会显著诱导菱形蛋白酶 RbdB、Dsc 泛素 E3 连接酶复合物和信号肽肽酶 SppA 的表达,这些蛋白酶对于 SrbA 的切割是必需的,这表明 HapB 作为这些基因的抑制剂,这些基因有助于通过蛋白水解切割激活 SrbA。总之,我们的研究表明,CBC 的功能不仅在于与 SrbA 竞争结合 erg11A 启动子区域,还在于影响 SrbA 的表达、切割和向核内易位,从而调节 Erg11A 的表达和唑类耐药性。